Clinical trial for Ligament; Laxity, Knee
Official title Ligament Balancing in Total Knee Arthroplasty
ClinicalTrials.gov ID: NCT06264076
What this study is testing
- What it's testing
- The goal of this interventional pilot study is to evaluate if performing ligament balancing on the medial collateral ligament (MCL) in a more systematical manner with a novel instrument can produce more objective and repeatable ligament lengthening in Total Knee Arthroplasty. The main questions it aim to answer are: 1.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Men and women over 40 years of age that require total knee arthroplasty
- Idiopathic osteoarthrosis, osteonecrosis or avascular osteonecrosis
- Otherwise fairly healthy/ no significant health issues
You likely can't join if
- Age under 40 years of age
- Pregnant
- Revisions or reoperations
- Considerable earlier injury to the knee
- Isolated patellofemoral osteoarthrosis
The study team makes the final eligibility decision.
Where it's taking place
- Bærums verk, Akershus, Norway
- Oslo, Oslo, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bærums verk, Akershus, Norway; Oslo, Oslo, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.